Safety and Immunogenicity Outcomes of an Inactivated Viral Vaccine against SARS-CoV-2 (Covaxin®)

Introduction: Bharat Biotech International Ltd in partnership with National Institute of Virology (NIV), has developed an indigenous whole virion inactivated Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) viral vaccine BBV-152 (Covaxin®), formulated with Toll Like Receptors 7/8 agonist...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Parul Sinha, Megha Gupta, Varunika Vijayvergia, Sushil Kumar Jain, Dinesh Kumar Jain, Sandeep Gupta, Monika Rathore, Nitya Vyas
বিন্যাস: প্রবন্ধ
ভাষা:English
প্রকাশিত: JCDR Research and Publications Private Limited 2022-09-01
মালা:Journal of Clinical and Diagnostic Research
বিষয়গুলি:
অনলাইন ব্যবহার করুন:https://jcdr.net/articles/PDF/16856/57170_CE(AD)_F[SH]_PF1(AG_SS)_PFA(AG_KM)_PN(KM).pdf